Elamipretide vs Efinopegdutide

Head-to-head comparison of Elamipretide (Elamipretide (MTP-131, SS-31)) and Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyElamipretideEfinopegdutide
CategoryMuscle & PerformanceWeight Management
Full NameElamipretide (MTP-131, SS-31)Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight639.8 DaN/A
Half-Life1-4 hoursApproximately 1 week
Amino Acids4N/A
Typical Dose0.01-0.25 mg/kg/dayTrial-dependent; weekly SC dosing
RouteSubcutaneous/IntravenousSubcutaneous
Purity≥98%≥98%
Studies Count12014
Research StatusClinicalClinical

Elamipretide Benefits

  • mitochondrial protection
  • reduced oxidative stress
  • improved fatigue resistance
  • may support exercise tolerance

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

Elamipretide Dosing

0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Elamipretide Side Effects

  • nausea
  • injection-site reactions
  • diarrhea
  • headache

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Research Overview

Elamipretide

Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Elamipretide stacks with:

creatinecoenzyme-q10protein

Efinopegdutide stacks with:

metforminorlistat
mitochondriafatigueenergy-metabolismperformanceglp1glucagondual-agonistobesitynash